title: Repeated chlorpromazine administration increases a behavioural response of rats to 5-hydroxytryptamine receptor stimulation.
abstract: 1 The hyperactivity syndrome produced in rats by administration of tranylcypromine (20 mg/kg i.p.) followed 30 min later by L-tryptophan (50 mg/kg i.p.) is generally considered to be due to increased 5-hydroxytryptamine (5-HT) functional activity. It is inhibited by chlorpromazine (30 mg/kg i.p.) injected 60 min before the tranylcypromine. However, chlorpromazine injection for 4 days either at a dose of 30 mg/kg once daily or 5 mg/kg twice daily results in an enhanced hyperactivity response to tranylcypromine and L-tryptophan administration 24 h after the final dose of chlorpromazine. 2 One injection of chlorpromazine (30 mg/kg) did not produce enhancement 24 h later and the inhibition of the tranylcypromine/L-tryptophan hyperactivity observed after acute chlorpromazine injection was seen if the rats were given tranylcypromine and L-tryptophan 1 h after the fourth chlorpromazine (30 mg/kg) dose. 3 Chlorpromazine (30 mg/kg) once daily or 5 mg/kg twice daily for 4 days resulted in rats displaying enhanced behavioral responses to the suggested 5-HT agonist 5-methoxy N,N-dimethyltryptamine (2 mg/kg) on day 5. 4 Chlorpromazine (30 mg/kg) once daily for 4 days produces a slight increase in brain 5-hydroxytryptamine (5-HT) concentration on day 5, but no difference in the rate of brain 5-HT synthesis or the rate of 5-HT accumulation after tranylcypromine and L-tryptophan administration. 5. There is some evidence that chlorpromazine blocks 5-HT receptors. It has also been observed that several other neuroleptic drugs do not produce enhanced 5-HT responses after repeated administration. It is suggested therefore that the enhanced behavioural response to 5-HT receptor stimulation following repeated chlorpromazine administration may be because this drug blocks 5-HT receptors.
mesh_terms: D000818:Animals; D001923:Brain Chemistry / Q000187:drug effects; D002746:Chlorpromazine / Q000008:administration & dosage / Q000494:pharmacology*; D004347:Drug Interactions; D009043:Motor Activity / Q000187:drug effects*; D004130:N,N-Dimethyltryptamine / Q000494:pharmacology; D051381:Rats; D011985:Receptors, Serotonin / Q000187:drug effects*; D012701:Serotonin / Q000032:analysis / Q000096:biosynthesis; D013268:Stimulation, Chemical; D013997:Time Factors; D014191:Tranylcypromine / Q000494:pharmacology; D014364:Tryptophan / Q000032:analysis / Q000494:pharmacology
chemical_list: D011985:Receptors, Serotonin; D012701:Serotonin; D014191:Tranylcypromine; D014364:Tryptophan; D002746:Chlorpromazine; D004130:N,N-Dimethyltryptamine
references.citation: J Neurochem. 1971 Jun;18(6):1053-66
references.pmid: 4254940
references.citation: Brain Res. 1975 Feb 7;84(2):257-67
references.pmid: 1078637
references.citation: J Pharmacol Exp Ther. 1976 Jul;198(1):23-32
references.pmid: 132525
references.citation: Neuropharmacology. 1974 Nov;13(10-11):949-59
references.pmid: 4437730
references.citation: Life Sci. 1974 Mar 1;14(5):887-98
references.pmid: 4828404
references.citation: Nature. 1976 Apr 8;260(5551):487-91
references.pmid: 817206
references.citation: Psychopharmacologia. 1975 Nov 21;44(3):297-300
references.pmid: 1082146
references.citation: Biochem Pharmacol. 1976 Aug 1;25(15):1743-6
references.pmid: 942477
references.citation: Br J Pharmacol. 1970 Jul;39(3):653-5
references.pmid: 5472211
references.citation: Adv Pharmacol. 1968;6(Pt A):97-109
references.pmid: 5664062
references.citation: J Lab Clin Med. 1967 Jan;69(1):160-9
references.pmid: 6018066
references.citation: Psychopharmacology (Berl). 1976 Sep 29;49(3):287-300
references.pmid: 12527
references.citation: Adv Neurol. 1975;9:93-104
references.pmid: 1146661
references.citation: Nat New Biol. 1973 Oct 31;245(148):262-3
references.pmid: 4518989
references.citation: Psychopharmacologia. 1969;15(2):96-101
references.pmid: 4390822